Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DANCANN PHARMA A/S
A/S
Active
Advertising protection
CVR 39426005
Rugvænget 5, 6823
Ansager
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 8 years old
7 employees
https://dancann.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
DANCANN PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
-5M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-5M
-9M
-14M
-19M
-6M
2020
-14M
-133%
2021
-15M
-7%
2022
-13M
+13%
2023
-5M
+62%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-4.830
0
0
0
0
Staff expenses
-947
-7.091
-7.496
-8.109
-4.774
EBITDA
-5.776
-13.864
-15.071
-13.408
-4.922
Depreciation & amort.
-94
-624
-955
-45.945
-750
EBIT
-5.870
-14.488
-16.026
-59.353
-5.672
Net financials
-116
-751
-2.417
-2.996
-2.674
Profit before tax
-5.986
-15.239
-18.443
-62.349
-8.346
Tax
-1.732
-3.489
-2.379
-89
-0
Net profit
-4.255
-11.750
-16.064
-62.260
-8.346
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
49.549
68.102
73.276
17.710
15.974
Equity
44.326
53.370
62.793
9.506
14.620
Long-term debt
24
0
0
0
0
Short-term debt
3.862
13.758
10.483
8.204
1.354
Total debt
3.886
13.758
10.483
8.204
1.354
Financial ratios
5-year trend
EBITDA margin
-492200000.0%
This company
15.8%
Market median
-3115189973% vs market
2020
2024
Equity ratio
91.5%
This company
38.2%
Market median
+140% vs market
2020
2024
Return on equity
-57.1%
This company
18.4%
Market median
-410% vs market
2020
2024
Net profit margin
-834600000.0%
This company
8.1%
Market median
-10303703804% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on DANCANN PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
